Morules but Not Squamous Differentiation are a Reliable Indicator of CTNNB1 (β-catenin) Mutations in Endometrial Carcinoma and Precancers-Reference-Cited by-同舟云学术

Morules but Not Squamous Differentiation are a Reliable Indicator of CTNNB1 (β-catenin) Mutations in Endometrial Carcinoma and Precancers

Published:2022-07-14 Issue:10 Volume:46 Page:1447-1455
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Niu Shuang,Lucas Elena,Molberg Kyle,Strickland Amanda,Wang Yan,Carrick Kelley,Rivera-Colon Glorimar,Gwin Katja,SoRelle Jeffrey A.,Castrillon Diego H.,Zheng Wenxin,Chen Hao

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference33 articles.

1. Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma;Zaino;Semin Diagn Pathol,1988

2. Endometrial adenocarcinoma with squamous cell differentiation;Abeler;Cancer,1992

3. The significance of squamous differentiation in endometrial carcinoma. Data from a Gynecologic Oncology Group study;Zaino;Cancer,1991

4. How to approach the many faces of endometrioid carcinoma;Malpica;Mod Pathol,2016

5. Adenoacanthosis of endometrium: a clinicopathologic study in premenopausal women;Crum;Am J Surg Pathol,1981

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. β-catenin, PAX2, and PTEN Aberrancy Across the Spectrum of Endometrioid Ovarian Lesions;International Journal of Gynecological Pathology;2024-07-31

2. Morules and β-catenin predict POLE mutation status in endometrial cancer: A pathway to more cost-effective diagnostic procedures;American Journal of Clinical Pathology;2024-03-21

3. Biomarkers in the Diagnosis of Endometrial Precancers. Molecular Characteristics, Candidate Immunohistochemical Markers, and Promising Results of Three-Marker Panel: Current Status and Future Directions;Cancers;2024-03-15

4. Predicting Progestin Therapy Response With PTEN, PAX2, and β-Catenin in Patients With Endometrioid Precancer;International Journal of Gynecological Pathology;2024-01-31

5. Endometrial Carcinoma. Low-Grade Endometrioid Carcinoma;Gynecologic and Obstetric Pathology;2024